Tesamorelin reconstitution & dose calculator
Enter your Tesamorelin vial size, the BAC water you added and your dose to see the units to draw on a U-100 insulin syringe.
- Strength
- 5 mg/mL
- 1 unit holds
- 50 mcg
Tesamorelin reconstitution chart: units to draw by vial size and BAC water
Find the row for the mg on your vial and the water you added. Amounts are from the range on our tesamorelin page, 1 to 2 mg. Units are on a U-100 insulin syringe, where 100 units is 1 mL.
| Vial | BAC water | Strength | Units to draw for | ||
|---|---|---|---|---|---|
| 1 mg | 1.5 mg | 2 mg | |||
| 5 mg | 1 mL | 5 mg/mL | 20 | 30 | 40 |
| 2 mL | 2.5 mg/mL | 40 | 60 | 80 | |
| 3 mL | 1.67 mg/mL | 60 | 90 | 120* | |
| 10 mg | 1 mL | 10 mg/mL | 10 | 15 | 20 |
| 2 mL | 5 mg/mL | 20 | 30 | 40 | |
| 3 mL | 3.33 mg/mL | 30 | 45 | 60 | |
| 12 mg | 1 mL | 12 mg/mL | 8.33 | 12.5 | 16.7 |
| 2 mL | 6 mg/mL | 16.7 | 25 | 33.3 | |
| 3 mL | 4 mg/mL | 25 | 37.5 | 50 | |
* Over 100 units: more than a 1 mL syringe holds in one draw. † Under 2 units: hard to measure; more water makes the draw bigger. Arithmetic from the numbers in each row. Pepdex does not pick a dose for you.
What to know about Tesamorelin before you mix it
Tesamorelin is a GHRH analog that is FDA-approved as Egrifta for HIV-associated lipodystrophy and studied for reducing visceral (deep abdominal) fat.
- How it is supplied
- Egrifta SV, the approved product, is a powder vial with its own mixing directions in the prescribing information. Research-grade tesamorelin is also freeze-dried powder.
- Common vial sizes
- 10 mg, 12 mg. Work from the mg printed on your own vial.
- Half-life
- Short: well under an hour on the Egrifta labels. It is taken once a day.
- Usual schedule on our page
- Once daily.
- FDA status
- Approved as Egrifta, 2010, for HIV-associated lipodystrophy.
- Evidence in one line
- 3 phase 3 and 26 indexed randomised-trial records; approved for HIV-associated visceral fat. Source: Pepdex evidence index, PubMed; Nat Rev Drug Discov 2011 (PMID 21283099).
What people track with Tesamorelin
- Daily shot time, ideally the same each day
- Waist size at the start and every 4 weeks, since it targets deep belly fat
- The 12-week mark, because the response builds over months
The common Tesamorelin mix-up
Using one product's directions for another. Egrifta SV's label sets the water volume for its own vial. A 10 mg research vial in 2 mL is 5 mg per mL, so 1 mg is 20 units.
Full Tesamorelin entry: evidence, side effects, FDA and WADA status
How long a Tesamorelin vial lasts
A 10 mg vial at 1 mg a shot holds 10 shots. Taken once a day, that is about 10 days. Shots per vial for each size:
| Vial | At 1 mg | At 1.5 mg | At 2 mg |
|---|---|---|---|
| 5 mg | 5 shots | 3 shots | 2 shots |
| 10 mg | 10 shots | 6 shots | 5 shots |
| 12 mg | 12 shots | 8 shots | 6 shots |
Tesamorelin reconstitution questions
- How much BAC water (reconstitution solution) do I add to a 10 mg Tesamorelin vial?
- Any amount works for the math; it only changes the strength. 10 mg in 1 mL is 10 mg/mL, in 2 mL 5 mg/mL, and in 3 mL 3.33 mg/mL. More water gives a bigger draw that is easier to read. If your product came with mixing directions, those set the volume.
- How many units is 1 mg of Tesamorelin?
- It depends on how much water is in the vial. From a 10 mg vial mixed with 2 mL, 1 mg is 20 units (0.2 mL). With 1 mL it is 10 units; with 3 mL, 30 units.
- How many 1 mg doses are in a 10 mg Tesamorelin vial?
- 10. Taken once a day, that lasts about 10 days. The water you add does not change the count, only the size of each draw.
- Is tesamorelin the same as CJC-1295?
- Both are GHRH analogs, but they are not interchangeable. Tesamorelin is a stabilized, FDA-approved molecule (Egrifta) studied for visceral fat; CJC-1295 is a research-grade GHRH analog. Different molecules, and their doses are not interchangeable.
Related calculators
Educational reference. Pepdex does not sell peptides or recommend vendors. The calculator and charts convert amounts into syringe units; whether an amount is right for you is a question for a qualified provider.